Faculty Opinions recommendation of Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical Trial.

2020 ◽  
Author(s):  
Maxine Gossell-Williams
Keyword(s):  
Breast Cancer ◽  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Phase 3

Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial

2021 ◽  
Vol 22 (4) ◽  
pp. 499-511 ◽  
Author(s):  
Eric P Winer ◽  
Oleg Lipatov ◽  
Seock-Ah Im ◽  
Anthony Goncalves ◽  
Eva Muñoz-Couselo ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Open Label ◽  
Phase 3 ◽  
Open Label Phase

scholarly journals Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer

JAMA Oncology ◽  
2019 ◽  
Vol 5 (8) ◽  
pp. 1132 ◽  
Author(s):  
Shaveta Vinayak ◽  
Sara M. Tolaney ◽  
Lee Schwartzberg ◽  
Monica Mita ◽  
Georgia McCann ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Clinical Trial ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Open Label

scholarly journals Corrigendum to: Subgroup analysis of Japanese patients in a Phase 3 study of atezolizumab in advanced triple-negative breast cancer (IMpassion130)

2020 ◽  
Vol 50 (2) ◽  
pp. 223-223
Author(s):  
Hiroji Iwata ◽  
Kenichi Inoue ◽  
Koji Kaneko ◽  
Yoshinori Ito ◽  
Koichiro Tsugawa ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Subgroup Analysis ◽  
Triple Negative ◽  
Japanese Patients ◽  
Phase 3
Sign in / Sign up

Export Citation Format

Share Document